Feasibility of Virtual Research Visits in Fox Trial Finder

Abstract Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or disability could prevent such individuals from participating in traditional, clinic-based research at major centers. Ob...

Full description

Saved in:
Bibliographic Details
Published inJournal of Parkinson's disease Vol. 5; no. 3; pp. 505 - 515
Main Authors Dorsey, E. Ray, Wagner, Joseph D., Bull, Michael T., Rizzieri, Ashley, Grischkan, Justin, Achey, Meredith A., Sherer, Todd, Chowdhury, Sohini, Meunier, Claire, Cappelletti, Lily, Rocker, Charlotte, Richard, Irene H., Schwarz, Heidi, Kang, Gail, Ahmad, Stacy H., Biemiller, Rachel A., Biglan, Kevin M.
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 14.09.2015
IOS Press
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or disability could prevent such individuals from participating in traditional, clinic-based research at major centers. Objective: Use videoconferencing to connect participants to specialists to: (1) demonstrate feasibility of virtual research visits within this population (2) collect phenotypic data of the participants, (3) validate self-reported diagnosis, and (4) gauge interest in virtual research visits. Methods: We solicited volunteers throughout the United States through Fox Trial Finder. Interested individuals with PD provided consent, were given web cameras if needed, completed baseline surveys, and downloaded videoconferencing software remotely. Participants had a test connection and assessment appointment which included the Montreal Cognitive Assessment (MoCA), then a virtual research visit with a neurologist who reviewed their history and assessed their PD using a modified Movement Disorders Society Unified Parkinson’s Disease Rating Scale. Neurologists assessed PD diagnosis and symptomatology. Physicians and participants were surveyed about their experience. Results: Of 204 individuals who consented, 166 (81% ) individuals from 39 states completed all visits. The mean age was 62 and mean disease duration was 8.0 years. Mean MoCA score was 26.5, and mean modified MDS-UPDRS motor score was 22.8 (out of a possible 124). Neurologists judged PD as the most likely diagnosis in 97% of cases. Overall satisfaction with the visits was 79% (satisfied or very satisfied) among neurologists and 93% among participants. Conclusions: Through virtual research visits, neurologists engaged, characterized, and validated self-reported diagnosis in individuals with PD over a broad geography. This model may facilitate future research participation.
AbstractList Abstract Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or disability could prevent such individuals from participating in traditional, clinic-based research at major centers. Objective: Use videoconferencing to connect participants to specialists to: (1) demonstrate feasibility of virtual research visits within this population (2) collect phenotypic data of the participants, (3) validate self-reported diagnosis, and (4) gauge interest in virtual research visits. Methods: We solicited volunteers throughout the United States through Fox Trial Finder. Interested individuals with PD provided consent, were given web cameras if needed, completed baseline surveys, and downloaded videoconferencing software remotely. Participants had a test connection and assessment appointment which included the Montreal Cognitive Assessment (MoCA), then a virtual research visit with a neurologist who reviewed their history and assessed their PD using a modified Movement Disorders Society Unified Parkinson’s Disease Rating Scale. Neurologists assessed PD diagnosis and symptomatology. Physicians and participants were surveyed about their experience. Results: Of 204 individuals who consented, 166 (81% ) individuals from 39 states completed all visits. The mean age was 62 and mean disease duration was 8.0 years. Mean MoCA score was 26.5, and mean modified MDS-UPDRS motor score was 22.8 (out of a possible 124). Neurologists judged PD as the most likely diagnosis in 97% of cases. Overall satisfaction with the visits was 79% (satisfied or very satisfied) among neurologists and 93% among participants. Conclusions: Through virtual research visits, neurologists engaged, characterized, and validated self-reported diagnosis in individuals with PD over a broad geography. This model may facilitate future research participation.
Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or disability could prevent such individuals from participating in traditional, clinic-based research at major centers. Use videoconferencing to connect participants to specialists to: (1) demonstrate feasibility of virtual research visits within this population (2) collect phenotypic data of the participants, (3) validate self-reported diagnosis, and (4) gauge interest in virtual research visits. We solicited volunteers throughout the United States through Fox Trial Finder. Interested individuals with PD provided consent, were given web cameras if needed, completed baseline surveys, and downloaded videoconferencing software remotely. Participants had a test connection and assessment appointment which included the Montreal Cognitive Assessment (MoCA), then a virtual research visit with a neurologist who reviewed their history and assessed their PD using a modified Movement Disorders Society Unified Parkinson's Disease Rating Scale. Neurologists assessed PD diagnosis and symptomatology. Physicians and participants were surveyed about their experience. Of 204 individuals who consented, 166 (81% ) individuals from 39 states completed all visits. The mean age was 62 and mean disease duration was 8.0 years. Mean MoCA score was 26.5, and mean modified MDS-UPDRS motor score was 22.8 (out of a possible 124). Neurologists judged PD as the most likely diagnosis in 97% of cases. Overall satisfaction with the visits was 79% (satisfied or very satisfied) among neurologists and 93% among participants. Through virtual research visits, neurologists engaged, characterized, and validated self-reported diagnosis in individuals with PD over a broad geography. This model may facilitate future research participation.
Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or disability could prevent such individuals from participating in traditional, clinic-based research at major centers. Objective: Use videoconferencing to connect participants to specialists to: (1) demonstrate feasibility of virtual research visits within this population (2) collect phenotypic data of the participants, (3) validate self-reported diagnosis, and (4) gauge interest in virtual research visits. Methods: We solicited volunteers throughout the United States through Fox Trial Finder. Interested individuals with PD provided consent, were given web cameras if needed, completed baseline surveys, and downloaded videoconferencing software remotely. Participants had a test connection and assessment appointment which included the Montreal Cognitive Assessment (MoCA), then a virtual research visit with a neurologist who reviewed their history and assessed their PD using a modified Movement Disorders Society Unified Parkinson’s Disease Rating Scale. Neurologists assessed PD diagnosis and symptomatology. Physicians and participants were surveyed about their experience. Results: Of 204 individuals who consented, 166 (81% ) individuals from 39 states completed all visits. The mean age was 62 and mean disease duration was 8.0 years. Mean MoCA score was 26.5, and mean modified MDS-UPDRS motor score was 22.8 (out of a possible 124). Neurologists judged PD as the most likely diagnosis in 97% of cases. Overall satisfaction with the visits was 79% (satisfied or very satisfied) among neurologists and 93% among participants. Conclusions: Through virtual research visits, neurologists engaged, characterized, and validated self-reported diagnosis in individuals with PD over a broad geography. This model may facilitate future research participation.
Author Grischkan, Justin
Wagner, Joseph D.
Achey, Meredith A.
Cappelletti, Lily
Rocker, Charlotte
Rizzieri, Ashley
Biemiller, Rachel A.
Biglan, Kevin M.
Schwarz, Heidi
Sherer, Todd
Kang, Gail
Dorsey, E. Ray
Richard, Irene H.
Meunier, Claire
Ahmad, Stacy H.
Chowdhury, Sohini
Bull, Michael T.
Author_xml – sequence: 1
  givenname: E. Ray
  surname: Dorsey
  fullname: Dorsey, E. Ray
  email: ray.dorsey@chet.rochester.edu
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 2
  givenname: Joseph D.
  surname: Wagner
  fullname: Wagner, Joseph D.
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 3
  givenname: Michael T.
  surname: Bull
  fullname: Bull, Michael T.
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 4
  givenname: Ashley
  surname: Rizzieri
  fullname: Rizzieri, Ashley
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 5
  givenname: Justin
  surname: Grischkan
  fullname: Grischkan, Justin
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 6
  givenname: Meredith A.
  surname: Achey
  fullname: Achey, Meredith A.
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 7
  givenname: Todd
  surname: Sherer
  fullname: Sherer, Todd
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 8
  givenname: Sohini
  surname: Chowdhury
  fullname: Chowdhury, Sohini
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 9
  givenname: Claire
  surname: Meunier
  fullname: Meunier, Claire
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 10
  givenname: Lily
  surname: Cappelletti
  fullname: Cappelletti, Lily
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 11
  givenname: Charlotte
  surname: Rocker
  fullname: Rocker, Charlotte
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 12
  givenname: Irene H.
  surname: Richard
  fullname: Richard, Irene H.
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 13
  givenname: Heidi
  surname: Schwarz
  fullname: Schwarz, Heidi
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 14
  givenname: Gail
  surname: Kang
  fullname: Kang, Gail
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 15
  givenname: Stacy H.
  surname: Ahmad
  fullname: Ahmad, Stacy H.
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 16
  givenname: Rachel A.
  surname: Biemiller
  fullname: Biemiller, Rachel A.
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
– sequence: 17
  givenname: Kevin M.
  surname: Biglan
  fullname: Biglan, Kevin M.
  organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26406130$$D View this record in MEDLINE/PubMed
BookMark eNptkN1KwzAYhoNM3Jw78QKkZ4JQTZqmaUEEmdYfBopM8Syk2dcto2tH0om7m13LrsyM6lBZThLyPe_7wXOIWmVVAkLHBJ_TgNKLx-cbnzDMwmQPdUjMuc9J_N7avjlpo561U-wOI5HLHKB2EIU4IhR30GUK0upMF7peelXuvWlTL2ThvYAFadTEfVhdW0-X61Vafa5XQ6PdONXlCMwR2s9lYaH3fXfRa3o77N_7g6e7h_71wFchj2qfRySAMOBRIpkEnAURSKISpoAoDARjUDEeESKBsyzOGIuJDKjKw0wqwnNKu-iq6Z0vshmMFJS1kYWYGz2TZikqqcXfSaknYlx9iDAJKMfcFZz8Ltgmfzw44KwBlKmsNZBvEYLFxrNwnkXj2cH4H6x0LWtdbZbrYnfktIlYOQYxrRamdMJ2kV8sz409
CitedBy_id crossref_primary_10_1017_cts_2022_459
crossref_primary_10_1007_s41347_022_00261_7
crossref_primary_10_1177_1742395316653453
crossref_primary_10_1055_s_0043_1768665
crossref_primary_10_1002_mds_29725
crossref_primary_10_3233_JPD_202249
crossref_primary_10_1038_nrd_2018_133
crossref_primary_10_3233_JPD_202402
crossref_primary_10_3390_geriatrics9030066
crossref_primary_10_1002_mdc3_12665
crossref_primary_10_1002_mds_28991
crossref_primary_10_1016_j_clinthera_2017_03_018
crossref_primary_10_1186_s12883_023_03403_3
crossref_primary_10_3233_JPD_202381
crossref_primary_10_1055_s_0042_1755323
crossref_primary_10_3233_JPD_202163
crossref_primary_10_3233_JPD_202121
crossref_primary_10_1002_acn3_51236
crossref_primary_10_1016_j_pec_2020_12_027
crossref_primary_10_1016_S1474_4422_17_30167_9
crossref_primary_10_1093_ptj_pzz133
crossref_primary_10_2196_53790
crossref_primary_10_2196_54145
crossref_primary_10_1016_j_gaitpost_2021_10_029
crossref_primary_10_3389_fneur_2024_1363513
crossref_primary_10_3389_fnhum_2023_1325215
crossref_primary_10_1111_bcp_15205
crossref_primary_10_3171_2021_8_FOCUS21383
crossref_primary_10_3233_JPD_223274
crossref_primary_10_1002_mdc3_12915
crossref_primary_10_1016_j_prdoa_2021_100094
crossref_primary_10_1212_CPJ_0000000000000680
crossref_primary_10_3233_JPD_202411
crossref_primary_10_1002_trc2_12055
crossref_primary_10_2196_47882
crossref_primary_10_3233_JPD_202019
crossref_primary_10_1017_cts_2024_498
crossref_primary_10_1136_bmjno_2021_000173
crossref_primary_10_1136_bmjopen_2022_063767
crossref_primary_10_3390_s21082821
crossref_primary_10_1089_tmj_2021_0117
crossref_primary_10_1155_2021_5534282
crossref_primary_10_1177_1357633X221146819
crossref_primary_10_1212_NXG_0000000000200008
crossref_primary_10_1212_CPJ_0000000000000882
Cites_doi 10.3233/JPD-140522
10.1016/0197-2456(87)90004-3
10.1056/NEJMc055540
10.1212/01.CPJ.0000437937.63347.5a
10.1016/j.parkreldis.2012.10.008
10.1177/014107689208500206
10.1200/JCO.2005.03.8976
10.1002/ana.20636
10.1001/jamaneurol.2013.123
10.1212/01.wnl.0000247740.47667.03
10.1002/mds.25357
10.1212/WNL.0b013e31822c9123
10.1016/S0197-2456(96)00236-X
10.1016/S0895-4356(99)00141-9
10.1002/mds.23145
10.1300/J010v19n02_01
10.1002/mds.25903
10.1002/mds.22340
10.1111/j.1468-0009.2011.00644.x
10.1097/JCP.0b013e3181d20912
10.1212/WNL.17.5.427
10.1002/mds.25814
10.1212/01.wnl.0000336652.05779.ea
10.1186/1744-859X-10-14
10.1016/j.parkreldis.2011.05.023
10.1001/jama.291.22.2720
10.1097/JCP.0b013e318192e4d7
10.1002/ana.21831
10.3109/00365548.2014.930966
10.1016/S0895-4356(01)00353-5
10.1016/S1470-2045(06)70576-9
10.1002/mds.24028
10.1016/S1353-8020(03)00066-X
ContentType Journal Article
Copyright IOS Press and the authors. All rights reserved
IOS Press and the authors. All rights reserved 2015
Copyright_xml – notice: IOS Press and the authors. All rights reserved
– notice: IOS Press and the authors. All rights reserved 2015
DBID AFRWT
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
5PM
DOI 10.3233/JPD-150549
DatabaseName Sage Journals GOLD Open Access 2024
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: AFRWT
  name: Sage Journals GOLD Open Access 2024
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate E.R. Dorsey et al
EISSN 1877-718X
EndPage 515
ExternalDocumentID PMC4923707
26406130
10_3233_JPD_150549
10.3233_JPD-150549
Genre Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
0R~
4.4
53G
ABDBF
ABIVO
ABJNI
ACGFS
ACPQW
ACPRK
ACUHS
ADZMO
AENEX
AFRHK
AFRWT
AFYTF
ALMA_UNASSIGNED_HOLDINGS
EBD
EJD
GROUPED_DOAJ
HZ~
IOS
J8X
MET
MIO
MV1
NGNOM
O9-
SAUOL
SCNPE
SFC
AAYXX
ACHEB
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
5PM
ID FETCH-LOGICAL-c476t-7612e42769a5ae0b26ea1c95ce1c0e100ec80d11ae75b8b5581a23cf4bac17f33
IEDL.DBID AFRWT
ISSN 1877-7171
IngestDate Thu Aug 21 13:17:23 EDT 2025
Thu Jan 02 23:04:54 EST 2025
Thu Apr 24 22:51:27 EDT 2025
Tue Jul 01 05:24:45 EDT 2025
Tue Jun 17 22:27:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Parkinson disease
telemedicine
Language English
License This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License.
This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c476t-7612e42769a5ae0b26ea1c95ce1c0e100ec80d11ae75b8b5581a23cf4bac17f33
OpenAccessLink https://journals.sagepub.com/doi/full/10.3233/JPD-150549?utm_source=summon&utm_medium=discovery-provider
PMID 26406130
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4923707
pubmed_primary_26406130
crossref_primary_10_3233_JPD_150549
crossref_citationtrail_10_3233_JPD_150549
sage_journals_10_3233_JPD_150549
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-09-14
PublicationDateYYYYMMDD 2015-09-14
PublicationDate_xml – month: 09
  year: 2015
  text: 2015-09-14
  day: 14
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: Netherlands
– name: Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands
PublicationTitle Journal of Parkinson's disease
PublicationTitleAlternate J Parkinsons Dis
PublicationYear 2015
Publisher SAGE Publications
IOS Press
Publisher_xml – name: SAGE Publications
– name: IOS Press
References Sharp (10.3233/JPD-150549_ref41) 2011; 10
10.3233/JPD-150549_ref42
10.3233/JPD-150549_ref23
Murthy (10.3233/JPD-150549_ref24) 2004; 291
Easterbrook (10.3233/JPD-150549_ref4) 1992; 85
Willis (10.3233/JPD-150549_ref32) 2011; 77
Nicoletti (10.3233/JPD-150549_ref34) 2003; 10
Hoehn (10.3233/JPD-150549_ref22) 1967; 17
Ross (10.3233/JPD-150549_ref10) 1999; 52
Dorsey (10.3233/JPD-150549_ref35) 2013; 28
Kobak (10.3233/JPD-150549_ref40) 2009; 29
Haidich (10.3233/JPD-150549_ref2) 2001; 54
Silberman (10.3233/JPD-150549_ref37) 2011; 89
Cubo (10.3233/JPD-150549_ref28) 2012; 27
Mills (10.3233/JPD-150549_ref9) 2006; 7
Ravina (10.3233/JPD-150549_ref38) 2010; 67
Valadas (10.3233/JPD-150549_ref12) 2011; 17
Lovato (10.3233/JPD-150549_ref1) 1997; 18
Achey (10.3233/JPD-150549_ref13) 2014; 29
Nasreddine (10.3233/JPD-150549_ref20) 2005; 53
Hunninghake (10.3233/JPD-150549_ref3) 1987; 8
Rocker (10.3233/JPD-150549_ref5) 2015; 5
Abdolahi (10.3233/JPD-150549_ref30) 2012; 19
Lesage (10.3233/JPD-150549_ref43) 2006; 354
Avis (10.3233/JPD-150549_ref8) 2006; 24
Trigo-Daporta (10.3233/JPD-150549_ref36) 2014; 46
Kobak (10.3233/JPD-150549_ref39) 2010; 30
Holden (10.3233/JPD-150549_ref6) 1993; 19
Goetz (10.3233/JPD-150549_ref19) 2008; 23
Dorsey (10.3233/JPD-150549_ref33) 2007; 68
Dorsey (10.3233/JPD-150549_ref14) 2013; 70
Karlawish (10.3233/JPD-150549_ref11) 2008; 71
Dorsey (10.3233/JPD-150549_ref29) 2010; 25
Tanner (10.3233/JPD-150549_ref31) 2014; 29
References_xml – volume: 5
  start-page: 55
  year: 2015
  ident: 10.3233/JPD-150549_ref5
  article-title: Use of an online portal to faciilitate clinical trial recruitment: A preliminary analysis of Fox Trial Finder
  publication-title: J Parkinsons Dis
  doi: 10.3233/JPD-140522
– volume: 8
  start-page: 6S
  year: 1987
  ident: 10.3233/JPD-150549_ref3
  article-title: Recruitment experience in clinical trials: Literature summary and annotated bibliography
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(87)90004-3
– volume: 354
  start-page: 422
  year: 2006
  ident: 10.3233/JPD-150549_ref43
  article-title: LRRK2 G2019S as a cause of Parkinson’s disease in North African Arabs
  publication-title: New Engl J Med
  doi: 10.1056/NEJMc055540
– ident: 10.3233/JPD-150549_ref23
  doi: 10.1212/01.CPJ.0000437937.63347.5a
– volume: 53
  start-page: 695
  year: 2005
  ident: 10.3233/JPD-150549_ref20
  article-title: The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
  publication-title: J Geriatr Psychiat
– volume: 19
  start-page: 218
  year: 2012
  ident: 10.3233/JPD-150549_ref30
  article-title: Potential reliability and validity of a modified version ofthe Unified Parkinson’s Disease Rating Scale that could beadministered remotely
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2012.10.008
– volume: 85
  start-page: 71
  year: 1992
  ident: 10.3233/JPD-150549_ref4
  article-title: Fate of research studies
  publication-title: J R Soc Med
  doi: 10.1177/014107689208500206
– volume: 24
  start-page: 1860
  year: 2006
  ident: 10.3233/JPD-150549_ref8
  article-title: Factors associated with participation in breast cancer treatment clinical trials
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.03.8976
– ident: 10.3233/JPD-150549_ref42
  doi: 10.1002/ana.20636
– volume: 70
  start-page: 565
  year: 2013
  ident: 10.3233/JPD-150549_ref14
  article-title: Randomizedcontrolled clinical trial of “virtual house calls” for Parkinsondisease
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2013.123
– volume: 68
  start-page: 384
  year: 2007
  ident: 10.3233/JPD-150549_ref33
  article-title: Projected number of people withParkinson disease in the most populous nations, 2005 through 2030
  publication-title: Neurol
  doi: 10.1212/01.wnl.0000247740.47667.03
– volume: 28
  start-page: 261
  year: 2013
  ident: 10.3233/JPD-150549_ref35
  article-title: Caring for the majority
  publication-title: Mov Disord
  doi: 10.1002/mds.25357
– volume: 77
  start-page: 851
  year: 2011
  ident: 10.3233/JPD-150549_ref32
  article-title: Neurologist care in Parkinson disease: A utilization, outcomes, and survival study
  publication-title: Neurol
  doi: 10.1212/WNL.0b013e31822c9123
– volume: 18
  start-page: 328
  year: 1997
  ident: 10.3233/JPD-150549_ref1
  article-title: Recruitment for controlled clinical trials: Literature summary and annotated bibliography
  publication-title: Control Clin Trials
  doi: 10.1016/S0197-2456(96)00236-X
– volume: 52
  start-page: 1143
  year: 1999
  ident: 10.3233/JPD-150549_ref10
  article-title: Barriers to participation in randomised controlled trials:A systematic review
  publication-title: J Clin Epidemiol
  doi: 10.1016/S0895-4356(99)00141-9
– volume: 25
  start-page: 1652
  year: 2010
  ident: 10.3233/JPD-150549_ref29
  article-title: Increasing access to specialty care:A pilot, randomized controlled trial of telemedicine forParkinson’s disease
  publication-title: Mov Disord
  doi: 10.1002/mds.23145
– volume: 19
  start-page: 1
  year: 1993
  ident: 10.3233/JPD-150549_ref6
  article-title: The recruitment of research participants: A review
  publication-title: Soc Work Health Care
  doi: 10.1300/J010v19n02_01
– volume: 29
  start-page: 871
  year: 2014
  ident: 10.3233/JPD-150549_ref13
  article-title: The past, present, and future of telemedicinefor Parkinson’s disease
  publication-title: Mov Disord
  doi: 10.1002/mds.25903
– volume: 23
  start-page: 2129
  year: 2008
  ident: 10.3233/JPD-150549_ref19
  article-title: Movement Disorder Society-sponsored revision ofthe Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
  publication-title: Mov Disord
  doi: 10.1002/mds.22340
– volume: 89
  start-page: 599
  year: 2011
  ident: 10.3233/JPD-150549_ref37
  article-title: Burdens on research imposed by institutional review boards: The state of the evidence and its implications for regulatory reform
  publication-title: Milbank Q
  doi: 10.1111/j.1468-0009.2011.00644.x
– volume: 30
  start-page: 193
  year: 2010
  ident: 10.3233/JPD-150549_ref39
  article-title: Site versuscentralized raters in a clinical depression trial: Impact on patient selection and placebo response
  publication-title: J ClinPsychopharmacol
  doi: 10.1097/JCP.0b013e3181d20912
– volume: 17
  start-page: 427
  year: 1967
  ident: 10.3233/JPD-150549_ref22
  article-title: Parkinsonism: Onset, progression and mortality
  publication-title: Neurology
  doi: 10.1212/WNL.17.5.427
– volume: 29
  start-page: 743
  year: 2014
  ident: 10.3233/JPD-150549_ref31
  article-title: A practicalapproach to remote longitudinal follow-up of Parkinson’s disease:The FOUND study
  publication-title: Mov Disord
  doi: 10.1002/mds.25814
– volume: 71
  start-page: 1883
  year: 2008
  ident: 10.3233/JPD-150549_ref11
  article-title: Howredesigning AD clinical trials might increase study partners’willingness to participate
  publication-title: Neurol
  doi: 10.1212/01.wnl.0000336652.05779.ea
– volume: 10
  start-page: 14
  year: 2011
  ident: 10.3233/JPD-150549_ref41
  article-title: The use of videoconferencing with patients with psychosis: A review of theliterature
  publication-title: Ann Gen Psychiatry
  doi: 10.1186/1744-859X-10-14
– volume: 17
  start-page: 667
  year: 2011
  ident: 10.3233/JPD-150549_ref12
  article-title: What motivatesParkinson’s disease patients to enter clinical trials?
  publication-title: Parkinson Relat Disord
  doi: 10.1016/j.parkreldis.2011.05.023
– volume: 291
  start-page: 2720
  year: 2004
  ident: 10.3233/JPD-150549_ref24
  article-title: Participation in cancerclinical trials: Race-, sex-, and age-based disparities
  publication-title: JAMA
  doi: 10.1001/jama.291.22.2720
– volume: 29
  start-page: 82
  year: 2009
  ident: 10.3233/JPD-150549_ref40
  article-title: Sources of unreliability in depression ratings
  publication-title: J Clin Psychopharmacol
  doi: 10.1097/JCP.0b013e318192e4d7
– volume: 67
  start-page: 258
  year: 2010
  ident: 10.3233/JPD-150549_ref38
  article-title: Local institutional review board (IRB) review of a multicentertrial: Local costs without local context
  publication-title: Ann Neurol
  doi: 10.1002/ana.21831
– volume: 46
  start-page: 737
  year: 2014
  ident: 10.3233/JPD-150549_ref36
  article-title: High-risk human papillomavirus in Galicia, Spain: Prevalence and evaluation of the sample representativeness
  publication-title: Scand J Infect Dis
  doi: 10.3109/00365548.2014.930966
– volume: 54
  start-page: 877
  year: 2001
  ident: 10.3233/JPD-150549_ref2
  article-title: Patterns of patient enrollment in randomized controlled trials
  publication-title: J Clin Epidemiol
  doi: 10.1016/S0895-4356(01)00353-5
– volume: 7
  start-page: 141
  year: 2006
  ident: 10.3233/JPD-150549_ref9
  article-title: Barriers to participation in clinical trialsof cancer: A meta-analysis and systematic review of patientreported factors
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(06)70576-9
– volume: 27
  start-page: 308
  year: 2012
  ident: 10.3233/JPD-150549_ref28
  article-title: Comparison of office-based versushome Web-based clinical assessments for Parkinson’s disease
  publication-title: Mov Disord
  doi: 10.1002/mds.24028
– volume: 10
  start-page: 19
  year: 2003
  ident: 10.3233/JPD-150549_ref34
  article-title: Prevalence of Parkinson’s disease: A door-to-door survey in rural Bolivia
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/S1353-8020(03)00066-X
SSID ssj0000516323
Score 2.249828
Snippet Abstract Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research....
Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or...
Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However,...
SourceID pubmedcentral
pubmed
crossref
sage
SourceType Open Access Repository
Index Database
Enrichment Source
Publisher
StartPage 505
SubjectTerms Feasibility Studies
Humans
Internet
Middle Aged
Parkinson Disease - diagnosis
Registries
Surveys and Questionnaires
Telemedicine - methods
United States
Videoconferencing
Title Feasibility of Virtual Research Visits in Fox Trial Finder
URI https://journals.sagepub.com/doi/full/10.3233/JPD-150549
https://www.ncbi.nlm.nih.gov/pubmed/26406130
https://pubmed.ncbi.nlm.nih.gov/PMC4923707
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LSyQxEC58XLyIi69xdWjYvXiIJp2k0wOC6LqNCIrI-Lg1nUwGB7RdZnoO_pv5LfPLrOoXjgh7TReku1Lp-ir1pQrgtx9kAxdbjE1UpJgaCscsdz3mvLCSexXLMqN7fRNd3qurJ_20BM_NXZhag5MjolXhG5U_a9rddBpNW1yGUh5f3V4wRDIY25xOi9e0Oudu2mnQCCWmp6-U03bEhHxnzb22ZVgNTaRxC6-eJXeP_fY8Bo0zkmU3OBEbwzDKEVU10y8TLviv1ml9JVR-YoWVjirZgPUaYQZnlUn8gCWfb8IJQr2aCPsevA2Dh9GYLo4EDfEOByajYhKM8vkMHdJ81ifDDBIqpjjegvvkb__PJasbJzCnTFQwg7DFK_zOXqYzz20Y-Uy4nsYFcNwLzr2L-UCIzBttY6t1LLJQuqGymRNmKOU2rORvud-FYCCVstZpa6zD2E_FiGh8rCPXowRuFnbgsFFH6uqq4tTc4iXF6IJUl6Lq0kp1HfjVyv6raml8K7VTKbOVQcxGqIN3wCyouRWgEtmLT_LRc1kqm8rPGW46ENCCpI11fTPt3v9FfsIawiVNbBGh9mGlGE_9AUKSwnbRms4vzpNubVVdWL65vf4AWgrjPg
linkProvider SAGE Publications
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1NT8JAEJ0oHPRiNH7hZxO9eKjudne7JfFCVIIIxBhQbk13u0QSUwzgwX_Db-GXOduWRgyJ13bSNm-nnTfdmTcAlyaOYh0ozE24z10-oNpVRFddbahixPCApTu67Y7f6PFmX_TzPm7bC5MjOLm2ZVX4ROnHOn-7mcfYTfP53kUSg2nNOpS5DVclKNfqL2_d4tcK-pnP0sFuNJDSxYSFZsKkfy6wFIqK-PO3NvJXgVcac-rbsJWTRaeWre4OrJlkF26RteU1rd_OaOC8Dse2B8RZ1NDhgclwOnGGyXyGsWU-61ofc-pWF3G8B736Q_eu4eYzEFzNpT91JTIQwz3pVyMRGaI830RUVwViqYmhhBgdkJjSyEihAiVEQCOP6QFXkaZywNg-lJJRYg7BiRnnSmmhpNKYxvEAyYkJhK-rdi828ipwtYAj1LlAuJ1T8RFiomChCxG6MIOuAheF7Wcmi7HS6iADs7BB-mUJBKmAXIK5MLBq18tnkuF7qnptleQkkRVw7IKEC0dZcduj_03OYaPRbbfC1mPn6Rg2kQUJWwRC-QmUpuMvc4pMY6rOcs_6AVVmzik
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LS8NAEB60BfEiiq_4DOjFQ3Q3u5tNwYuowWcpUh-3kN1ssCBpaevBf-Nv6S9zNkmDlYLXZEjCt7OZb3ZnvwE4NmmS6lBhbsID7vGMak8R3fK0oYoRw0NW7Og-toObZ373Jt6qpQt7FqZCcHRqy6rwi4qftZ3dgzSzM5z5jJ3dda48JDKY2ixCk3MMig1oXkRPr916eQV9LWBFczcaSulh0kJLcdI_D5gJR3UM-lsf-avIq4g70SqsVITRvShHeA0WTL4O58jcqrrWL7efuS-9oT0H4k7r6PDCqDceub188o3xZfLdtX7mRlYbcbgBz9F19_LGq_ogeJrLYOxJZCGG-zJoJSIxRPmBSahuCcRTE0MJMTokKaWJkUKFSoiQJj7TGVeJpjJjbBMaeT832-CmjHOltFBSaUzleIgExYQi0C27H5v4DpxM4Yh1JRJue1V8xJgsWOhihC4uoXPgqLYdlNIYc622SjBrG6RglkQQB-QMzLWBVbyevZP33gvla6smJ4l0wLUDEk-dZc5rd_43OYSlzlUUP9y273dhGYmQsHUglO9BYzz8NPtINsbqoHKsH3K6zzk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Feasibility+of+Virtual+Research+Visits+in%C2%A0Fox%C2%A0Trial+Finder&rft.jtitle=Journal+of+Parkinson%27s+disease&rft.au=Dorsey%2C+E.+Ray&rft.au=Wagner%2C+Joseph+D.&rft.au=Bull%2C+Michael+T.&rft.au=Rizzieri%2C+Ashley&rft.date=2015-09-14&rft.pub=IOS+Press&rft.issn=1877-7171&rft.eissn=1877-718X&rft.volume=5&rft.issue=3&rft.spage=505&rft.epage=515&rft_id=info:doi/10.3233%2FJPD-150549&rft_id=info%3Apmid%2F26406130&rft.externalDocID=PMC4923707
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1877-7171&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1877-7171&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1877-7171&client=summon